Back to RNA
FARALLON CAPITAL MANAGEMENT, L.L.C. → RNA
FARALLON CAPITAL MANAGEMENT, L.L.C. RNA Position History
Atrium Therapeutics, Inc. • Healthcare
Quarters held
1
Latest value
$4.7M
Q1 2026
Peak value
$4.7M
First seen
Q1 2026
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q1 2026 | $4.7M | 349.4K | — | — |